India Cardiac Resynchronization Therapy (CRT) Market Size, Share & Trends Analysis Report By Product (CRT-Defibrillator, CRT-Pacemaker), By End User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users) and Forecasts, 2026-2034

Market Overview

The India Cardiac Resynchronization Therapy (CRT) Market size was valued at USD 306 million in 2025 and is projected to grow from USD 336.97 million in 2026 to reach USD 728.65 million by 2034, growing at a CAGR of 10.12% during the forecast period 2026–2034.

Cardiac resynchronization therapy (CRT) is a treatment that assists the heart in beating at the correct rate. It employs a pacemaker to restore the heartbeat's normal timing pattern. The CRT pacemaker coordinates the synchronization of the heart's upper (atria) and lower (ventricles) chambers. It also regulates the synchronization between the heart's left and right sides.

The market for cardiac resynchronization therapy (CRT) was estimated to be worth USD 5.85 billion in 2021. One of the major trends accelerating market expansion is the rapid advancement of technology. The market is expanding due to sedentary lifestyle adoption, an aging population, and increased cardiovascular disease prevalence.

India Cardiac Resynchronization Therapy (CRT) Market Segmentation Analysis

By Product

The India Cardiac Resynchronization Therapy (CRT) Market is segmented into CRT-Defibrillator and CRT-Pacemaker. CRT-Defibrillators combine cardiac resynchronization capabilities with implantable cardioverter-defibrillator functionality, helping improve ventricular synchronization while providing protection against potentially life-threatening ventricular arrhythmias. CRT-Pacemakers are primarily designed to coordinate ventricular contractions and improve cardiac function in eligible patients with heart failure and conduction abnormalities. CRT-Defibrillators represent the leading product segment in India, supported by their combined resynchronization and defibrillation capabilities and increasing demand for advanced cardiac rhythm management solutions.

Increasing prevalence of cardiovascular diseases, growing incidence of heart failure and arrhythmias, rising awareness of advanced cardiac therapies, and improvements in healthcare infrastructure are supporting demand across both product categories. CRT-Pacemakers are also gaining importance as diagnosis and management of heart failure and conduction disorders improve across the country. Technological advancements in device design, battery performance, lead technology, remote monitoring, and intelligent pacing are expected to strengthen adoption of CRT systems, while increasing disposable incomes and expanding access to specialized cardiac care are supporting market development in India.

Request Customizationto receive a tailored report.

By End User

The India Cardiac Resynchronization Therapy (CRT) Market is segmented into Hospitals, Cardiac Centers, Ambulatory Surgical Centers, and Other End Users. Hospitals represent the leading end-user segment because CRT implantation requires specialized cardiovascular infrastructure, diagnostic capabilities, trained cardiac specialists, and post-procedure monitoring. Cardiac centers provide specialized services for cardiovascular diagnosis, device implantation, rhythm management, and patient follow-up, while ambulatory surgical centers are increasingly relevant for selected procedures that can be performed in outpatient settings. Other end users include specialized healthcare facilities and medical institutions involved in cardiac rhythm management and cardiovascular care.

Growing demand for advanced cardiac treatment, increasing prevalence of heart failure and cardiac rhythm disorders, expansion of specialized cardiac facilities, and improving access to cardiovascular services are supporting demand across end-user settings. Hospitals continue to benefit from their comprehensive cardiac-care infrastructure, while cardiac centers are gaining importance because of their specialized expertise and increasing focus on advanced rhythm-management procedures. Ambulatory surgical centers can benefit from the expansion of outpatient cardiac interventions, while remote monitoring and improved follow-up technologies are supporting long-term management of CRT patients. Rising healthcare expenditure, increasing cardiac health awareness, and continued expansion of healthcare infrastructure are expected to support CRT adoption across India.

Speak to an Analystto discuss market opportunities.

Regional Analysis of the Cardiac Resynchronization Therapy (CRT) Market

According to a study that was published in the Indian Heart Journal in December 2018, only 116 out of 471 heart failure patients (24.6%) chose to have a CRT device implanted because of economic reasons. After two years, it was discovered that patients who received CRT had better clinical outcomes. Over the forecast period, rising disposable income, expanding healthcare infrastructure, and rising cardiac health awareness are expected to drive the market. International competitors are also growing their operations to take market share in the nation. Abbott supported its growth goals by introducing a new portfolio of CRT-Ds and ICDs in India in October 2020.

List of Key and Emerging Players in India Cardiac Resynchronization Therapy (CRT) Market